Prothena Corp. (PRTA) CEO Schenk Passed Away
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Prothena Corp. (NASDAQ: PRTA) said CEO Dale Schenk, PhD, has passed away, according to Bloomberg. Schenk had pancreatic cancer.
Schenk took medical leave just on September 26th. For more color, click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viacom (VIAB) said close to naming Bakish as Interim CEO - Bloomberg
- Aerojet Rocketdyne (AJRD) Taps United Tech's Lundstrom as CFO
- Concordia International (CXRX) CEO to Step Down
Create E-mail Alert Related CategoriesHot Mgmt Changes, Management Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!